Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$362K Buy
3,008
+1
+0% +$115 0.19% 114
2025
Q4
$317K Sell
3,007
-26
-0.9% -$2.44K 0.16% 125
2025
Q3
$255K Sell
3,033
-62
-2% -$5.11K 0.14% 148
2025
Q2
$245K Sell
3,095
-606
-16% -$48.2K 0.16% 143
2025
Q1
$332K Sell
3,701
-30
-0.8% -$2.8K 0.22% 104
2024
Q4
$371K Buy
3,731
+72
+2% +$7.42K 0.26% 92
2024
Q3
$416K Buy
3,659
+105
+3% +$12.5K 0.26% 96
2024
Q2
$440K Buy
3,554
+864
+32% +$111K 0.31% 85
2024
Q1
$355K Buy
2,690
+66
+3% +$8.13K 0.25% 102
2023
Q4
$286K Sell
2,624
-146
-5% -$15.2K 0.22% 114
2023
Q3
$285K Buy
2,770
+308
+13% +$33.2K 0.25% 108
2023
Q2
$284K Hold
2,462
0.24% 111
2023
Q1
$262K Sell
2,462
-1,100
-31% -$119K 0.23% 109
2022
Q4
$395K Buy
3,562
+398
+13% +$40.7K 0.38% 68
2022
Q3
$272K Buy
3,164
+177
+6% +$15.8K 0.3% 89
2022
Q2
$272K Hold
2,987
0.3% 92
2022
Q1
$245K Buy
2,987
+10
+0.3% +$788 0.24% 102
2021
Q4
$228K Buy
+2,977
New +$237K 0.23% 116

Other funds holding MRK

Carson Advisory's MRK Position: Q1 2026 in Review

Carson Advisory increased its Merck (MRK) stake by 0.03% in Q1 2026, buying an estimated $115 and bringing the position to 3,008 shares worth $362K. The position accounts for 0.19% of the portfolio, ranked #114.

Carson Advisory first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $440K in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Carson Advisory held 3,008 shares of Merck worth $362K as of Q1 2026.
  • Carson Advisory bought 1 Merck share in Q1 2026, an estimated $115.
  • Merck made up 0.19% of Carson Advisory's portfolio in Q1 2026, its #114 holding.
  • Carson Advisory first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Carson Advisory's Merck position peaked at $440K in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.